Mustang Bio announces opening of CAR T cell therapy manufacturing facility in Worcester
Mustang Bio announced it has opened a CAR T cell therapy manufacturing facility at UMass Medicine Science Park in Worcester, Mass. The 27,000 sq. ft. facility will support the clinical development and commercialization of Mustang’s CAR T product candidates. June 22, 2018